Sialadenosis in bulimia. A new treatment.
OBJECTIVE
To see whether a cholinomimetic medication would help resolve the parotid gland enlargement associated with self-induced vomiting in bulimic patients.


METHODS
The medication was administered on an inpatient eating disorder unit to bulimic patients with refractory sialadenosis.


METHODS
Pilocarpine hydrochloride drops were administered orally at a dosage of 1.25 to 5.0 mg/d until the parotid gland enlargement was significantly reduced.


RESULTS
There was a marked diminution in the size of the parotid gland enlargement.


CONCLUSIONS
Pilocarpine has proved to be beneficial in the treatment of sialadenosis in bulimic patients.
Mehler
P S
PS
Department of Internal Medicine, Columbine Hospital, Littleton, CO 80126.
Wallace
J A
JA
D000328:Adult; D002032:Bulimia / Q000150:complications*; D005260:Female; D006801:Humans; D006984:Hypertrophy; D010305:Parotid Diseases / Q000188:drug therapy* / Q000209:etiology*; D010862:Pilocarpine / Q000627:therapeutic use
D010862:Pilocarpine